Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
about
Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillationEmerging directions in the genetics of atrial fibrillationA contemporary review on the genetic basis of atrial fibrillation.Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathwaysAtrial Fibrillation and SCN5A Variants.Genetics of atrial fibrillation and possible implications for ischemic stroke.Recent advances in the molecular pathophysiology of atrial fibrillation.Novel pharmacological targets for the rhythm control management of atrial fibrillation.Your Father and Grandfather's Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac DysrhythmiaAtrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillationThe Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?A KCNJ8 mutation associated with early repolarization and atrial fibrillation.Genetic mechanisms of atrial fibrillation: impact on response to treatmentComplex inheritance in Pulmonary Arterial Hypertension patients with several mutations.Atrial fibrillation: the role of common and rare genetic variants.Atrial fibrillation: mechanisms, therapeutics, and future directions.Lone atrial fibrillation: what is known and what is to come.Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.Cardiac Delayed Rectifier Potassium Channels in Health and Disease.Genotype influence in responses to therapy for atrial fibrillation.Arrhythmic complications of tyrosine kinase inhibitors.EvoTol: a protein-sequence based evolutionary intolerance framework for disease-gene prioritization.Systems-level approaches reveal conservation of trans-regulated genes in the rat and genetic determinants of blood pressure in humans.Does Atrial Fibrillation Follow Function? Ion Channel Mutations and Lone Atrial FibrillationRate-Dependent Role of IKur in Human Atrial Repolarization and Atrial Fibrillation Maintenance.Genistein and tyrphostin AG556 decrease ultra-rapidly activating delayed rectifier K+ current of human atria by inhibiting EGF receptor tyrosine kinase.Familial clustering of atrial fibrillation and comparative longitudinal outcomes of familial and non-familial atrial fibrillation
P2860
Q24306905-DEA5553F-6079-438C-849B-3D9FCA256741Q26852051-502F6E34-F72C-429E-B76F-47439F9CCEDBQ33732880-3F50ADA8-8956-4D58-8D74-5546BAB58D37Q33769113-5DC2D85E-595B-4DF3-A9F8-2F6FF03E44B2Q33923776-04457BC2-A0D1-43EC-A684-BCA0B8443096Q34626371-9F7FB516-FE87-4572-B0A1-23DB686F2D1AQ35142380-466F03DC-6E94-4CB9-A828-42B45BC1F2E4Q35142870-E7056B5D-5623-48E4-ABB7-9D3E7DC676A2Q35489060-B89E5C5B-9F9A-4FC2-B5B5-3E9C8AF51632Q35742142-2225B50C-CE2D-465C-AE25-CAF5B0B253C1Q36013079-289A7C38-A78B-453B-B318-39372DF579DCQ36252497-91B06C58-A8EA-4A8D-8831-6E5D9F351584Q36264955-EB8259E0-7383-4F7C-A7A2-66784B5E7672Q36280780-D806CD9F-9CC8-471E-88EC-996F68896474Q36876093-5FAC48AB-4E1D-4DCA-A4D8-0996AD0D449DQ37257895-05B9CFDC-338E-46C3-BE39-7AA9459E0CEEQ37585850-20D5D29E-DCAA-4AB1-BF67-B1FF98835477Q37590158-7DAE9AF0-59E3-49AF-89DC-FE6000A829C7Q37827195-7EC346C8-145E-44E2-B6F0-C55D1B0BC20FQ37998525-A57E0FAD-236F-4B50-89B4-964E8FF3E1C6Q38854252-BAE07051-AD5D-4721-9D7F-15BF80A29D6CQ38894994-106E3E17-E99B-4631-A7D4-D79473B5812AQ38978097-E6716C81-2FDA-4109-99C0-6785A3059BA4Q41637558-4661F690-3B55-4853-83A3-6C983A674CAAQ41821529-F8655AB4-2DB5-47BD-9738-15674B2043EDQ42565539-ACB2A789-9F65-4C12-9EE6-3AF6A9F3F155Q47849876-98C090A1-8802-481E-96A5-398311E4D732Q48367671-E72D02D4-62D9-410F-AC82-2B81FD54EC93Q57260272-A18A1EDA-D1F6-4212-8D71-A0F64D8AE52F
P2860
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@ast
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@en
type
label
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@ast
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@en
prefLabel
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@ast
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@en
P2093
P2860
P1433
P1476
Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation
@en
P2093
P2860
P304
P356
10.1016/J.HRTHM.2010.05.032
P577
2010-06-01T00:00:00Z